Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Sabora pharma Oy
OY
Active
Y-tunnus 1089311-3
Tammelantie 10, 03600
Karkkila
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1997 · 29 years old
28 employees
www.sabora.fi
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Sabora pharma Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
3M
7M
10M
14M
7M
2021
8M
2022
10M
2023
12M
2024
12M
2025
EBITDA
EUR millions
3M
2M
1M
1M
0M
1M
2021
1M
0%
2022
2M
+100%
2023
2M
0%
2024
2M
0%
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
6 628
7 814
10 297
11 596
11 560
Staff expenses
−1 187
−1 277
−1 646
−1 762
−1 950
EBITDA
1 010
1 289
1 952
2 109
2 033
Depreciation & amort.
−22
−23
−26
−6
−4
EBIT
989
1 266
1 926
2 103
2 029
Net financials
20
−2
9
52
112
Profit before tax
1 009
1 263
1 935
2 155
2 142
Tax
197
254
387
422
418
Net profit
812
1 009
1 548
1 733
1 724
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
5 112
5 636
7 164
7 899
9 401
Equity
3 462
4 201
5 419
6 722
7 916
Long-term debt
101
31
2
2
2
Short-term debt
1 550
1 404
1 743
1 175
1 484
Total debt
1 650
1 435
1 744
1 177
1 486
Financial ratios
5-year trend
EBITDA margin
17.6%
This company
15.8%
Market median
+11% vs market
2021
2025
Equity ratio
84.2%
This company
38.2%
Market median
+120% vs market
2021
2025
Return on equity
21.8%
This company
18.4%
Market median
+18% vs market
2021
2025
Net profit margin
14.9%
This company
8.1%
Market median
+84% vs market
2021
2025
Asset turnover
1.23×
This company
1.12×
Market median
+10% vs market
2021
2025
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Sabora pharma Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
